Composition:
Each 1 ml contains: Entecavir as (monohydrate) 50μg.
Indication:
Chronic hepatitis B in patients with compensated liver disease (withevidence of viral replication, and histologically documented active liver inflammation or fibrosis) not previously treated with nucleoside analogues
Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) and lamivudine-resistance
Chronic hepatitis B in patients with decompensated liver disease